Clinical Trials Logo

Coronary Arteriosclerosis clinical trials

View clinical trials related to Coronary Arteriosclerosis.

Filter by:

NCT ID: NCT00368953 Completed - Clinical trials for Coronary Arteriosclerosis

YUKON Choice Versus TAXUS Liberté in Diabetes Mellitus

Start date: September 2006
Phase: Phase 4
Study type: Interventional

Revascularisation procedures such as percutaneous coronary intervention are associated with overall worse outcomes in patients with diabetes mellitus. Implantation of coronary stents is associated with higher restenosis rates compared to non-diabetic individuals. There is only limited data available on the efficacy and safety of the novel Yukon Choice drug-eluting stent system specifically in patients with diabetes mellitus. The trial will determine the efficacy and safety of the novel Yukon Choice stent system compared to the well established Taxus Liberté stent system. The primary endpoint will be "in-stent late lumen loss" at 9 months as determined by invasive angiography.

NCT ID: NCT00365196 Completed - Clinical trials for Coronary Arteriosclerosis

Hostility Reduction Program to Improve Autonomic Regulation of the Heart

Start date: December 1999
Phase: N/A
Study type: Interventional

Individuals who experience high hostility levels may be more prone to developing coronary artery disease (CAD) than individuals who experience low hostility levels. This study will evaluate the effectiveness of a hostility reduction treatment program on the body's ability to regulate heart activity in individuals with high levels of hostility.

NCT ID: NCT00357955 Completed - Hypertension Clinical Trials

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Start date: August 2004
Phase: N/A
Study type: Interventional

The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.

NCT ID: NCT00356135 Completed - Clinical trials for Acute Coronary Syndrome

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event

SWAP
Start date: July 2006
Phase: Phase 2
Study type: Interventional

This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS).

NCT ID: NCT00353795 Completed - Clinical trials for Coronary Artery Disease

Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)

Start date: July 2005
Phase: N/A
Study type: Interventional

The overall goal of this study is to use MRI to: - Examine the relationship between known risk factors for cardiovascular disease and coronary artery wall thickness; - Examine the relationship between coronary artery wall thickness and other markers of subclinical coronary atherosclerosis, such as carotid wall thickness and coronary calcium scores; and, - Examine the feasibility of measuring the progression of coronary artery wall thickness over time in a subset of participants.

NCT ID: NCT00352937 Completed - Clinical trials for Coronary Arteriosclerosis

Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test

Start date: March 2006
Phase: Phase 3
Study type: Observational

To compare the efficacy of 16-row multi-detector CT (MDCT) with standard myocardial perfusion imaging in detecting coronary artery disease (CAD) in patients without a previously established diagnosis of CAD.

NCT ID: NCT00351676 Completed - Clinical trials for Diabetes Mellitus, Type 2

Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment

Start date: February 2006
Phase: Phase 4
Study type: Interventional

We, the researchers, propose to link a clinical pharmacist with an internal medicine or family medicine team to provide pharmaceutical care to all patients assigned to the team. The hypothesis is that through this team based approach, pharmacists will act as a resource for providing pharmacotherapeutic advice during the drug therapy decision making process and promote optimal drug use by identifying and resolving actual and potential drug related problems. This study is designed to test this hypothesis, by assessing the impact of this intervention on evidence based, quality of drug therapy indicators, for patients admitted with heart failure (HF), chronic obstructive pulmonary disease (COPD), community acquired pneumonia (CAP), type 2 diabetes mellitus (T2DM), and stable coronary artery disease (CAD).

NCT ID: NCT00345631 Completed - Clinical trials for Coronary Arteriosclerosis

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral artery following a cardiac or peripheral diagnostic or interventional procedure while maintaining the same level of safety.

NCT ID: NCT00328848 Completed - Hypertension Clinical Trials

After Discharge Management of Low Income Frail Elderly

Start date: October 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether comprehensive post-hospitalization interdisciplinary care management can be an effective care delivery model to improve outcomes in low-income frail elderly.

NCT ID: NCT00325611 Completed - Stroke Clinical Trials

Multidisciplinary Inpatient Palliative Care Intervention

Start date: April 2002
Phase: N/A
Study type: Interventional

Palliative care is believed to improve care of patients with life-limiting illnesses. This study evaluated the impact of a multi-center randomized trial of a palliative care team intervention on the quality and cost of care of hospitalized patients. Study subjects were randomized to intervention or usual care. At study end, patients receiving the palliative care intervention reported greater patient satisfaction with their care. Intervention patients also had significantly fewer ICU admissions and lower total costs for care 6 months past their hospitalization. Intervention patients completed more advance directives and had longer hospice stays.